Impact of Bacteremia on the Pathogenesis of Experimental Pneumococcal Meningitis
Open Access
- 15 January 2008
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 197 (2) , 235-244
- https://doi.org/10.1086/524874
Abstract
Background. Bacteremia plays a major role in the outcome of pneumococcal meningitis. This experimental study investigated how bacteremia influences the pathophysiologic profile of the brain. Methods. Rats with Streptococcus pneumoniae meningitis were randomized to 1 of 3 groups of infected study rats: (1) rats with attenuated bacteremia resulting from intravenous injection of serotype-specific pneumococcal antibody, (2) rats with early-onset bacteremia resulting from concomitant intravenous infection, or (3) a meningitis control group. The blood-brain barrier (BBB) breakdown, ventricle size, brain water distribution, and brain pathologic findings were analyzed using magnetic resonance morphological and functional imaging. Laboratory data and clinical disease scores were obtained. Results. Attenuation of the bacteremic component of pneumococcal meningitis improved clinical disease symptoms and significantly reduced ventricle expansion and BBB breakdown (P < .05). Early-onset bacteremia did not further increase ventricle size or BBB leakage. Significantly increased brain edema developed among rats with both attenuated and early-onset bacteremia (P < .05). Focal brain pathologic findings were unaffected by bacteremia and were found to be associated with cerebrospinal fluid inflammation. Conclusion. Although brain lesions appear to result from local meningeal infection, systemic infection significantly contributes to clinical disease presentation and the pathophysiology of BBB breakdown and ventricle expansion. The different end points affected by the systemic and local infectious processes should be addressed in future studies.Keywords
This publication has 29 references indexed in Scilit:
- Complement C1q and C3 Are Critical for the Innate Immune Response to Streptococcus pneumoniae in the Central Nervous SystemThe Journal of Immunology, 2007
- Evaluation of anti-pneumococcal capsular antibodies as adjunctive therapy in experimental pneumococcal meningitisJournal of Antimicrobial Chemotherapy, 2006
- Cell Wall-Mediated Neuronal Damage in Early SepsisInfection and Immunity, 2006
- Blocking of leukocyte accumulation in the cerebrospinal fluid augments bacteremia and increases lethality in experimental pneumococcal meningitisJournal of Neuroimmunology, 2005
- Clinical Features and Prognostic Factors in Adults with Bacterial MeningitisNew England Journal of Medicine, 2004
- Attenuation of the Bacterial Load in Blood by Pretreatment with Granulocyte-Colony-Stimulating Factor Protects Rats from Fatal Outcome and Brain Damage duringStreptococcus pneumoniaeMeningitisInfection and Immunity, 2004
- MyD88 is required for mounting a robust host immune response to Streptococcus pneumoniae in the CNSBrain, 2004
- Experimental Pneumococcal Meningitis: Impaired Clearance of Bacteria from the Blood Due to Increased Apoptosis in the Spleen in Bcl-2-Deficient MiceInfection and Immunity, 2004
- Cerebral Histopathology following Portal Venous Infusion of Bacteria in a Chronic Porcine ModelAnesthesiology, 2000
- Pathophysiology of septic encephalopathy: A reviewCritical Care Medicine, 2000